Macrolide resistance and genotypic characterization of Streptococcus pneumoniae in Asian countries: A study of the Asian Network for Surveillance of Resistant Pathogens (ANSORP)

Journal of Antimicrobial Chemotherapy

Volumn 53, Issue 3, 2004, Pages 457-463

  Song, Jae Hoon ^a   Chang, Hyun Ha ^b   Suh, Ji Yoeun ^c   Ko, Kwan Soo ^c   Jung, Sook In ^d   Oh, Won Sup ^a   Peck, Kyong Ran ^a   Lee, Nam Yong ^a   Yang, Yonghong ^e   Chongthaleong, Anan ^f   Aswapokee, Nalinee ^g   Chiu, Cheng Hsun ^h   Lalitha, M K ⁱ   Perera, Jennifer ^j   Yee, Ti Teow ^k   Kumararasinghe, Gamini ^k   Jamal, Farida ^l   Kamarulazaman, Adeeba ^m   Parasakthi, Navaratnam ^m   Van, Pham Hung ⁿ   So, Thomas ^o   Ng, Tak Keung ^o   more..

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Kyung Hee University College of Medicine   (South Korea)

^c Asia Pacific Foundation for Infectious Diseases (APFID)   (South Korea)

^d Chonnam National University Medical School   (South Korea)

^e CAPITAL MEDICAL UNIVERSITY   (China)

^f CHULALONGKORN UNIVERSITY   (Thailand)

^g MAHIDOL UNIVERSITY   (Thailand)

^h CHANG GUNG CHILDREN S HOSPITAL   (Taiwan)

ⁱ CHRISTIAN MEDICAL COLLEGE   (India)

^j UNIVERSITY OF COLOMBO   (Sri Lanka)

^k NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^l UNIVERSITY PUTRA MALAYSIA   (Malaysia)

^m UNIVERSITY OF MALAYA   (Malaysia)

ⁿ UNIVERSITY OF MEDICINE AND PHARMACY AT HO CHI MINH CITY   (Viet Nam)

^o PRINCESS MARGARET HOSPITAL   (Hong Kong)

more..

Author keywords

erm(B); Erythromycin; mef(A); Pneumococci

Indexed keywords

AZITHROMYCIN; BACTERIAL PROTEIN; CLARITHROMYCIN; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; MACROLIDE; PENICILLIN G;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; ASIA; BACTERIUM ISOLATE; CHINA; CLONE; CONTROLLED STUDY; GENETIC CODE; GENETIC EPIDEMIOLOGY; GENOTYPE; HONG KONG; HORIZONTAL GENE TRANSFER; HUMAN; INDIA; KOREA; MALAYSIA; METHYLATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHENOTYPE; PREVALENCE; RIBOSOME; SINGAPORE; SRI LANKA; STREPTOCOCCUS PNEUMONIAE; TAIWAN; THAILAND; VIET NAM;

ALLELES; ANTI-BACTERIAL AGENTS; ASIA; BACTERIAL PROTEINS; DRUG RESISTANCE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; ERYTHROMYCIN; GENOTYPE; HUMANS; MACROLIDES; MEMBRANE PROTEINS; MICROBIAL SENSITIVITY TESTS; PNEUMOCOCCAL INFECTIONS; POPULATION SURVEILLANCE; SEROTYPING; STREPTOCOCCUS PNEUMONIAE;

EID: 12144291202     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkh118     Document Type: Article

References (33)

1. Adam, D. (2002). Global antibiotic resistance in Streptococcus pneumoniae. Journal of Antimicrobial Chemotherapy 50, Topic T1, 1-5.
2. Song, J.-H., Lee, N. Y., Ischiyama S. et al. (1999). Spread of drug-resistant Streptococcus pneumoniae in Asian countries. Clinical Infectious Diseases 28, 1206-11.
3. Appelbaum, P. C. (2002). Resistance among Streptococcus pneumoniae: Implications for drug selection. Clinical Infectious Diseases 34, 1613-20.
4. Hyde, T. B., Gay, K., Stephens, D. S. et al. (2001). Macrolide resistance among invasive Streptococcus pneumoniae isolates. Journal of the American Medical Association 286, 1857-62.
5. Lee, N. Y., Song, J. H., Kim, S. et al. (2001). Carriage of antibiotic-resistant pneumococci among Asian children: A multinational surveillance by the Asian Network for Surveillance of Resistant Pathogens (ANSORP). Clinical Infectious Diseases 32, 1463-9.
6. Jacobs, M. R., Felmingham, D., Appelbaum, P. C. et al. (2003). The Alexander project 1998-2000: Susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents. Journal of Antimicrobial Chemotherapy 52, 229-46.
7. Amsden, G. W. (1999). Pneumococcal macrolide resistance - myth or reality? Journal of Antimicrobial Chemotherapy 44, 1-6.
8. Leclercq, R. & Courvalin, P. (2002). Resistance to macrolides and related antibiotics in Streptococcus pneumoniae. Antimicrobial Agents and Chemotherapy 46, 2727-34.
9. Weisblum, B. (1995). Erythromycin resistance by ribosome modification. Antimicrobial Agents and Chemotherapy 39, 577-85.
10. Jonston, N. J., De Azavedo, J. C., Kellner, J. D. et al. (1998). Prevalence and characterization of the mechanisms of macrolide, lincosamide, and streptogramin resistance in isolates of Streptococcus pneumoniae. Antimicrobial Agents and Chemotherapy 42, 2425-6.
11. Fitoussi, F., Doit, C., Geslin, P. et al. (2001). Mechanisms of macrolide resistance in clinical pneumococcal isolates in France. Antimicrobial Agents and Chemotherapy 45, 636-8.
12. National Committee for Clinical Laboratory Standards. (2000). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically - Fifth Edition: Approved Standard M7-A5. NCCLS, Wayne, PA, USA.
13. Sutcliffe, J., Grebe, T., Tait-Kamradt, A. et al. (1996). Detection of erythromycin-resistant determinants by PCR. Antimicrobial Agents and Chemotherapy 40, 2562-6.
14. Clancy, J., Peptipas, J., Dib-Hajj, F. et al. (2000). Antibiotic susceptibility and serotype distribution of Streptococcus pneumoniae causing meningits in Italy, 1997-1999. Clinical Infectious Diseases 31, 1373-9.
15. Tenover, F. C., Arbeit, R. D., Goering, R. V. et al. (1995). Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: Criteria for bacterial strain typing. Journal of Clinical Microbiology 33, 2233-9.
16. Enright, M. C. & Spratt, B. C. (1998). A multilocus sequence typing scheme for Streptococcus pneumoniae: Identification of clones associated with serious invasive disease. Microbiology 144, 3049-69.
17. Felmingham, D. & Gruneberg, R. N. (2000). The Alexander Project 1999 preliminary results: Penicillin and macrolide resistance in S. pneumoniae from Europe. In Abstracts of the Fortieth Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Canada, 2000. Abstract 1790, p. 108. American Society for Microbiology, Washington, DC, USA.
18. Thornsberry, C., Ogilvie, P. T., Holley, H. P. et al. (1999). Survey of susceptibilities of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis isolates to 26 antimicrobial agents: A prospective U.S. study. Antimicrobial Agents and Chemotherapy 43, 2612-23.
19. Ip, M., Lyon, D. J., Yung, R. W. et al. (2001). Macrolide resistance in Streptococcus pneumoniae in Hong Kong. Antimicrobial Agents and Chemotherapy 45, 1578-80.
20. Hsueh, P. R., Teng, L. J., Lee, L. N. et al. (2002). Increased prevalence of erythromycin resistance in streptococci: substantial upsurge in erythromycin-resistant M phenotype in Streptococcus pyogenes (1979-1998) but not in Streptococcus pneumoniae (1985-1999) in Taiwan. Microbial Drug Resistance 8, 27-33.
21. Farrell, D. J., Morrissey, I., Bakker, S. et al. (2002). Molecular characterization of macrolide resistance mechanisms among Streptococcus pneumoniae and Streptococcus pyogenes isolated from the PROTEKT 1999-2000 study. Journal of Antimicrobial Chemotherapy 50, 39-47.
22. Shortridge, V. D., Doern, G. V., Brueggemann, A. B. et al. (1999). Prevalence of macrolide resistance mechanisms in Streptococcus pneumoniae isolates from a multicenter antibiotic resistance surveillance study conducted in the United States in 1994-1995. Clinical Infectious Diseases 29, 1186-8.
23. Lagrou, K., Peetermans, W. E., Verhaegen, J. et al. (2000). Macrolide resistance in Belgian Streptococcus pneumoniae. Journal of Antimicrobial Chemotherapy 45, 119-21.
24. Marcheses, A., Tonoli, E., Debbia, E. A. et al. (1999). Macrolide resistance mechanisms and expression of phenotypes among Streptococcus pneumoniae circulating in Italy. Journal of Antimicrobial Chemotherapy 44, 461-4.
25. Pihlajamaki, M., Kaijalainen, T., Huovinen, P. et al. (2002). Rapid increase in macrolide resistance among penicillin non-susceptible pneumococci in Finland, 1996-2000. Journal of Antimicrobial Chemotherapy 49, 785-92.
26. Schmitz, F. J., Perdikouli, M., Beeck, A. et al. (2001). Molecular surveillance of macrolide, tetracycline and quinolone resistance mechanisms in 1191 clinical European Streptococcus pneumoniae isolates. International Journal of Antimicrobial Agents 18, 433-6.
27. Reinert, R. R., Al-Lahham, A., Lemperle, M. et al. (2002). Emergence of macrolide and penicillin resistance among invasive pneumococcal isolates in Germany. Journal of Antimicrobial Chemotherapy 49, 61-8.
28. Lonks, J. R., Garay, J. & Medeiros, A. A. (2002). Implications of antimicrobial resistance in the empirical treatment of community-acquired respiratory infections: The case of macrolides. Journal of Antimicrobial Chemotherapy 50, Suppl. S2, 87-91.
29. Kays, M. B., Wack, M. F., Smith, D. W. et al. (2002). Azithromycin treatment failure in community-acquired pneumonia caused by Streptococcus pneumoniae resistant to macrolides by a 23S rRNA mutation. Diagnostic Microbiology and Infectious Disease 43, 163-5.
30. Musher, D. M., Dowell, M. E., Shortridge, V. D. et al. (2002). Emergence of macrolide resistance during treatment of pneumococcal pneumonia. New England Journal of Medicine 346, 630-1.
31. McGee, L., McDougal, L., Zhou, J. et al. (2001). Nomenclature of major antimicrobial-resistant clones of Streptococcus pneumoniae defined by the pneumococcal molecular epidemiology network. Journal of Clinical Microbiology 39, 2565-71.
32. Shi, Z.-Y., Enright, M. C., Wilkinson, P. et al. (1998). Identification of three major clones of multiply antibiotic-resistant Streptococcus pneumoniae in Taiwanese hospitals by multilocus sequence typing. Journal of Clinical Microbiology 36, 3514-9.
33. Chiou, C. C. & McEllistrem, M. C. (2001). Novel penicillin-, cephalosporin-, and macrolide-resistant clones of Streptococcus pneumoniae serotype 23F and 19F in Taiwan which differ from international epidemic clones. Journal of Clinical Microbiology 39, 1144-7.